Taysha Gene Therapies (TSHA) Other Gross PP&E Adjustments (2022 - 2025)
Taysha Gene Therapies (TSHA) has disclosed Other Gross PP&E Adjustments for 4 consecutive years, with $671000.0 as the latest value for Q4 2025.
- Quarterly Other Gross PP&E Adjustments fell 65.82% to $671000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $671000.0 through Dec 2025, down 65.82% year-over-year, with the annual reading at $671000.0 for FY2025, 65.82% down from the prior year.
- Other Gross PP&E Adjustments hit $671000.0 in Q4 2025 for Taysha Gene Therapies, down from $3.2 million in the prior quarter.
- In the past five years, Other Gross PP&E Adjustments ranged from a high of $61.3 million in Q3 2022 to a low of $671000.0 in Q4 2025.
- Historically, Other Gross PP&E Adjustments has averaged $10.0 million across 4 years, with a median of $3.8 million in 2023.
- Biggest five-year swings in Other Gross PP&E Adjustments: crashed 94.49% in 2023 and later soared 43.53% in 2025.
- Year by year, Other Gross PP&E Adjustments stood at $5.3 million in 2022, then decreased by 26.16% to $3.9 million in 2023, then crashed by 49.58% to $2.0 million in 2024, then tumbled by 65.82% to $671000.0 in 2025.
- Business Quant data shows Other Gross PP&E Adjustments for TSHA at $671000.0 in Q4 2025, $3.2 million in Q3 2025, and $2.0 million in Q2 2025.